
Keywords: MZR; mizoribine; MMF; mycophenolate mofetil; RCTs; randomized controlled trials; CMV; cytomegalovirus; HZV; Herpes zoster virus; BKV; Polyomavirus BK; CNIs; calcineurin inhibitors; AZA; azathioprine; CsA; cyclosporine; ITT; intention-to-treat; IMPDH; inos